ロード中...
Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States
BACKGROUND: Hepatitis C virus (HCV) treatment as prevention (TasP) strategies can contribute to HCV microelimination, yet complimentary interventions such as opioid agonist therapies (OAT) with methadone or buprenorphine and syringe services programs (SSPs) may improve the prevention impact. This mo...
保存先:
| 出版年: | Clin Infect Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7935393/ https://ncbi.nlm.nih.gov/pubmed/32060534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa142 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|